ArticleGenes & diseases2024

Corrigendum to "A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis" [Genes & Diseases 11 (2024) 479-494].

Yanran Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.